// App-Quantinova.ai

Tu1943 : Higher Activity of the Inducible Nitric Oxide Synthase Contributes to Very Early Onset of Inflammatory Bowel Disease

Researchers

Presenter

  • Lucas A. Mastropaolo

Principal Investigators

  • Cornelia E. Thoeni

  • Karoline Fiedler

  • John Brumell

  • Scott Snapper

  • Aleixo M. Muise

  • Abdul A. Elkadri

  • Wei Xu

  • Thomas D. Walters

  • Conghui Guo

  • David R. Mack

  • Hien q. Huynh

  • Shairaz Baksh

  • Mark S. Silverberg

Medical Centers

  • Division of Hematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada

  • Division of Pediatric Gastroenterology & Nutrition, Stollery Children's Hospital, Edmonton, AB, Canada

  • Division of Cell Biology, Medical University Innsbruck, Innsbruck, Austria

  • interNational Early Onset Pediatrics IBD Cohort Study, Toronto, ON, Canada

  • Division of Pediatric Gastroenterology, Hepatology, Nutrition, Department of Medicine, Boston Children's Hospital, Boston, MA

  • Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.

  • Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada

  • Division of Gastroenterology, Hepatology and Nutrition, Hospital for Sick Children, Toronto, ON, Canada

  • Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

Locations

  • United States

  • Canada

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Infectious Diseases (ID)

  • Genetic Disorder

Disease

  • Inflammatory bowel disease

Biomarkers

  • N/A

Drug/Treatment

  • Nitric oxide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved